Home
E-Submission
Sitemap
Contact Us
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Management team
Open access
Best practice
Contact us
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Funded articles
Search
Author index
EDITORIAL POLICY
Research and publication ethics
Peer review policy
Data archiving policy
Data sharing policy
Advertising policies
FOR CONTRIBUTORS
Instructions to authors
Author’s checklist
Copyright transfer agreement
E-submission
Article-processing charge
Search
Previous issues
Page Path
HOME
BROWSE ARTICLES
Previous issue
Volume 3(1); Jan 2023
Review Article
Sleep disturbances in autoimmune encephalitis
Dae Lim Koo
encephalitis.
2023;3(1):1-6. Published online December 26, 2022
DOI:
https://doi.org/10.47936/encephalitis.2022.00073
Cited By 1
Full text
PubReader
ePub
PDF
Original Articles
Low serum complement level is associated with higher mortality in tuberculous meningitis: a retrospective cohort study
Hansol Im, Taewon Kim, Seunghee Na et al.
encephalitis.
2023;3(1):7-14. Published online December 14, 2022
DOI:
https://doi.org/10.47936/encephalitis.2022.00059
Full text
PubReader
ePub
PDF
Regulatory T cell profiles in patients with
N
-methyl-ᴅ-aspartate receptor-antibody encephalitis
Mildred A. Iro, Christine S. Rollier, Sarosh R. Irani et al.
encephalitis.
2023;3(1):15-23. Published online January 3, 2023
DOI:
https://doi.org/10.47936/encephalitis.2022.00052
Cited By 1
Full text
PubReader
ePub
PDF
Improving performance robustness of subject-based brain segmentation software
Jong-Hyeok Park, Kyung-Il Park, Dongmin Kim et al.
encephalitis.
2023;3(1):24-33. Published online January 6, 2023
DOI:
https://doi.org/10.47936/encephalitis.2022.00108
Full text
PubReader
ePub
PDF
Supplementary Material
Case Report
Autoimmune limbic encephalitis combined with leptomeningeal metastases of non-small cell lung cancer: treatment response to osimertinib, immunoglobulin, rituximab, and tocilizumab
Seolah Lee, Seon-Jae Ahn, Han Sang Lee, Kon Chu
encephalitis.
2023;3(1):34-38. Published online January 6, 2023
DOI:
https://doi.org/10.47936/encephalitis.2022.00122
Full text
PubReader
ePub
PDF
MOST VIEWED
MOST CITED
4,438
Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases
5,150
Posttransplant lymphoproliferative disorder in a kidney transplant recipient: a case of Epstein-Barr virus-positive primary central nervous system lymphoma
7,866
Clinical significance of Epstein-Barr virus polymerase chain reaction in cerebrospinal fluid
3,729
Lumbar puncture: considerations, procedure, and complications
2,970
Management of convulsive status epilepticus: recent updates
+more
Cited By
2
Management of convulsive status epilepticus: recent updates
Cited By
2
Protein biomarkers in multiple sclerosis
Cited By
1
Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report
Cited By
1
Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy
Cited By
1
Chronic social stress during early development elicits unique behavioral changes in adulthood
+more
ABOUT
Aims and scope
About the journal
Editorial board
Management team
Open access
Best practice
Contact us
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Funded articles
Search
Author index
EDITORIAL POLICY
Research and publication ethics
Peer review policy
Data archiving policy
Data sharing policy
Advertising policies
FOR CONTRIBUTORS
Instructions to authors
Author’s checklist
Copyright transfer agreement
E-submission
Article-processing charge